熱門資訊> 正文
United Health因盈利前景疲软而陷入困境,拖累同行走低
2025-07-29 17:57
- UnitedHealth press release (NYSE:UNH): Q2 Non-GAAP EPS of $4.08 misses by $0.37.
- Revenue of $111.62B (+12.9% Y/Y) in-line.
- UnitedHealth Group’s second quarter 2025 revenues grew $12.8 billion year-over-year to $111.6 billion, driven by growth within UnitedHealthcare and Optum.
- The second quarter consolidated medical care ratio of 89.4% increased 430 basis points year-over-year. The increase was primarily due to medical cost trends which significantly exceeded pricing trends, including both unit costs and the intensity of services delivered, and the ongoing effects of Medicare funding reductions.
- Days claims payable of 44.5 compared to 45.5 in the first quarter 2025 and 45.2 in second quarter 2024.
- The second quarter 2025 operating cost ratio of 12.3% compared to 13.3% in the year ago quarter reflecting business mix, inclusive of the Part D program changes, reduced impacts from last year’s Change Healthcare cyberattack and cost management activities. The full year 2025 operating cost ratio is now expected to be 12.75% +/- 25 basis points.
- Full Year 2025 Revenue Outlook of $445.5 Billion to $448.0 Billion vs $449.07B consensus
- Full Year 2025 Earnings Outlook of at least $14.65 Per Share, Adjusted Earnings of at least $16.00 Per Share vs $20.90 consensus
- UNH shares -7% PM.
- Fellow managed care insurers Humana (HUM), Elevance Health (ELV), Centene (CNC), Molina (MOH), and Oscar Health (OSCR) are also trading lower.
More on UnitedHealth
- UnitedHealth Group: The Ceiling, The Floor, And Extreme Uncertainties (Downgrade)
- UnitedHealth: Turning Into A Falling Knife
- UnitedHealth Back To 2020 Levels: Why I'm Buying Into Q2 Earnings
- Medicare Part D premiums will sharply rise in 2026 - report
- UnitedHealth faces critical test as Q2 results loom
風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。